GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
Sample GSM2237209 Query DataSets for GSM2237209
Status Public on Jul 20, 2016
Title 02-096 1
Sample type protein
Source name serum
Organism Homo sapiens
Characteristics subject id: 096
visit number (1 = baseline): 1
Sex: F
elevated liver enzyme [ast, alk, or alk-phos at pre-treatment visit (v1). 0 = no, 1 = yes]: N
multiple em (y = multiple erythema migrans lesions, n = single erythema migrans lesion): N/A
illness duration (days of illness prior to treatment beginning): N/A
# of symptoms: N/A
fatigue severity [range from 9-63] scores ≥36 are considered "high"]: 27
ptlds status [ptlds status 0 = returned to health, 1 = symptoms only, 2 = ptlds]: N/A
mcgill pain total score (range 0-45): 3
Extracted molecule protein
Extraction protocol Serum was isolated from coagulated blood using standard protocols. All sera were frozen and aliquoted within four hours of sampling.
Label PE
Label protocol Spectrally-distinct polystyrene beads with magnetic cores were covalently coupled to capture antibodies by the manufacturer. All assays were performed using 96-well flat-bottom plates and a Bio-Plex Pro II magnetic wash station. Standards, quality controls and experimental sera were diluted in provided diluents and then incubated with the respective multiplex bead mix according to manufacturer protocol.
Hybridization protocol Incubation with the appropriate biotinylated detection antibody cocktail was performed as outlined in the protocol, followed by incubation with streptavidin-PE. Following the final wash step, beads were re-suspended in the designated buffer.
Scan protocol Plates were analyzed using a Luminex 200 (Luminex Corporation, Austin, TX, USA) in combination with Bio-Plex Manager 5.0 software (Bio-Rad Laboratories, Hercules, CA, USA).
Data processing Serum concentrations were interpolated from standard curves for each respective analyte in Bio-Plex Manager 5.0 software. Values out of range below the standard curve were set to zero, while any value out of range above the standard curve was set to 4x the highest observed standard concentration. For descriptive analyses of the multiplex biomarker data, data were analyzed using the log of the “ratio to cohort average”. This value was computed for each analyte by first setting any value less than 1 pg/mL to 1 pg/mL and then calculating the log base 2 of [(observed value)/(average value in the cohort)].
Submission date Jul 15, 2016
Last update date Jul 20, 2016
Contact name William Robinson
Phone 650-849-1207
Organization name Stanford University
Street address 269 Campus Dr
City Stanford
State/province CA
ZIP/Postal code 94305
Country USA
Platform ID GPL18408
Series (1)
GSE84479 CCL19 as a Chemokine Risk Factor for Posttreatment Lyme Disease

Data table header descriptions
VALUE Ratio to cohort average, log2

Data table
1 167.61
2 1
3 1
4 15.22
5 1
6 1
7 54.6
8 11.1
9 1
10 1
11 1
12 29.06
13 59.2
14 1
15 15.38
16 897.26
17 36.52
18 1
19 22.55
20 122.49

Total number of rows: 65

Table truncated, full table size <1 Kbytes.

Supplementary data files not provided
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap